학술논문

Epigenomic response to albuterol treatment in asthma-relevant airway epithelial cells
Document Type
article
Source
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-16 (2023)
Subject
Airway cells
Albuterol
β2-agonist
CREB3L1
DNA methylation
Epigenetics
Medicine
Genetics
QH426-470
Language
English
ISSN
1868-7083
Abstract
Abstract Background Albuterol is the first-line asthma medication used in diverse populations. Although DNA methylation (DNAm) is an epigenetic mechanism involved in asthma and bronchodilator drug response (BDR), no study has assessed whether albuterol could induce changes in the airway epithelial methylome. We aimed to characterize albuterol-induced DNAm changes in airway epithelial cells, and assess potential functional consequences and the influence of genetic variation and asthma-related clinical variables. Results We followed a discovery and validation study design to characterize albuterol-induced DNAm changes in paired airway epithelial cultures stimulated in vitro with albuterol. In the discovery phase, an epigenome-wide association study using paired nasal epithelial cultures from Puerto Rican children (n = 97) identified 22 CpGs genome-wide associated with repeated-use albuterol treatment (p